Akslen, Lars A.
Universitetet i Bergen,
Norway
2023 Rank: 104192
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3723 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104192 | 101050 |
| Total Cites | 1698 | 1901 |
| H-index | 14 | 16 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 53 | 53 |
| Total Cites to Single+First Authored Papers | 31 | 33 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 356 | 416 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1530 | 1617 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.18 |
| Self-Citation Percentage |
10.68%
|
|
Akslen, Lars A.
Haukeland Universitetssjukehus,
Norway
2022 Rank: 69653
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2655 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69653 | 76306 |
| Total Cites | 1794 | 1934 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 43 | 44 |
| Number of Single+First+Last Authored Papers | 162 | 162 |
| Total Cites to Single+First+Last Authored Papers | 389 | 421 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1648 | 1721 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.12 |
| Self-Citation Percentage |
7.24%
|
|
Akslen, Lars A.
Universitetet i Bergen,
Norway
2021 Rank: 69050
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2502 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 69050 | 75741 |
| Total Cites | 2826 | 3047 |
| H-index | 18 | 19 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 47 | 49 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 593 | 640 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2580 | 2697 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
7.25%
|
|
Akslen, Lars A.
Universitetet i Bergen,
Norway
2020 Rank: 81242
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2844 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81242 | 89662 |
| Total Cites | 2072 | 2227 |
| H-index | 15 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 38 | 41 |
| Number of Single+First+Last Authored Papers | 156 | 156 |
| Total Cites to Single+First+Last Authored Papers | 416 | 455 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1886 | 1963 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
6.96%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.